Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107M
-
Number of holders
-
163
-
Total 13F shares, excl. options
-
75.9M
-
Shares change
-
+6.87M
-
Total reported value, excl. options
-
$1.49B
-
Value change
-
+$146M
-
Put/Call ratio
-
0.04
-
Number of buys
-
104
-
Number of sells
-
-61
-
Price
-
$19.57
Significant Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q4 2022
196 filings reported holding RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share as of Q4 2022.
ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) has 163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.9M shares
of 107M outstanding shares and own 70.74% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (17.7M shares), BlackRock Inc. (5.59M shares), VANGUARD GROUP INC (4.19M shares), STATE STREET CORP (3.98M shares), WELLINGTON MANAGEMENT GROUP LLP (3.51M shares), MAVERICK CAPITAL LTD (3.4M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2.91M shares), CITADEL ADVISORS LLC (2.6M shares), RA CAPITAL MANAGEMENT, L.P. (2.41M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.89M shares).
This table shows the top 163 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.